Different stages in drug development for muscle-invasive bladder cancer.

about

Different stages in drug development for muscle-invasive bladder cancer.

Item

http://www.wikidata.org/entity/Q48022703

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Different stages in drug development for muscle-invasive bladder cancer.

@en

Different stages in drug development for muscle-invasive bladder cancer.

@nl

type

Item

label

Different stages in drug development for muscle-invasive bladder cancer.

@en

Different stages in drug development for muscle-invasive bladder cancer.

@nl

prefLabel

Different stages in drug development for muscle-invasive bladder cancer.

@en

Different stages in drug development for muscle-invasive bladder cancer.

@nl

P1476

Different stages in drug development for muscle-invasive bladder cancer.

@en

P2093

Gallus Beatus Ineichen

http://www.w3.org/2001/XMLSchema#string

Kevin Fabian Johner

http://www.w3.org/2001/XMLSchema#string

Raphael Röthlisberger

http://www.w3.org/2001/XMLSchema#string

Roland Seiler

http://www.w3.org/2001/XMLSchema#string

P2860

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

A Network Map of FGF-1/FGFR Signaling System.

Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy

Evidence for the involvement of VAR2CSA in pregnancy-associated malaria.

Fibroblast growth factor receptors-1 and -3 play distinct roles in the regulation of bladder cancer growth and metastasis: implications for therapeutic targeting.

Phase III, Double-Blind, Randomized Trial That Compared Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 1/2-Positive Metastatic Bladder Cancer.

Chondroitin sulfate A is a cell surface receptor for Plasmodium falciparum-infected erythrocytes

Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein.

The FGF family: biology, pathophysiology and therapy

Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib.

P304

1060-1066

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/TAU.2017.11.22

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29354493

http://www.w3.org/2001/XMLSchema#string

P932

5760381

http://www.w3.org/2001/XMLSchema#string